Sangamo Biosciences Inc. (NASDAQ:SGMO) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company.
Sangamo Biosciences Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased to $-0.10 in the quarter versus EPS of $-0.11 in the year-earlier quarter.
Revenue: Rose 50.98% to $6.9 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Sangamo Biosciences Inc. reported adjusted EPS loss of $0.10 per share. By that measure, the company beat the mean analyst estimate of $-0.13. It beat the average revenue estimate of $4.77 million.
Key Stats (on next page)…
Revenue increased 49.35% from $4.62 million in the previous quarter. EPS increased to $-0.10 in the quarter versus EPS of $-0.13 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0.14 to a loss $0.12. For the current year, the average estimate has moved up from a loss of $0.54 to a loss of $0.48 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)